Dapagliflozin News

Dapagliflozin currently has 12 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Dapagliflozin with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Type 2 diabetes mellitus Dapagliflozin Viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to...
Evidence level: L5
Predicted indications (20):
- classic stiff person syndrome (98.2%)
- focal stiff limb syndrome (98.2%)
- opsismodysplasia (98.1%)
- thiamine-responsive dysfunction syndrome (98.0%)
- diabetes mellitus (disease) (97.9%)
- drug-induced localized lipodystrophy (97.0%)
- centrifugal lipodystrophy (96.9%)
- pressure-induced localized lipoatrophy (96.8%)
- idiopathic localized lipodystrophy (96.7%)
- pancreatic agenesis (96.6%)
- autoimmune oophoritis (90.4%)
- type 1 diabetes mellitus (90.3%)
- diabetes mellitus, insulin-dependent, X-linked, susceptibility to (63.2%)
- atrial flutter (disease) (62.7%)
- cholangiocarcinoma, susceptibility to (62.2%)
- hemoglobin C-beta-thalassemia syndrome (62.0%)
- retinal dystrophy with or without extraocular anomalies (61.8%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (59.4%)
- congenital temporomandibular joint ankylosis (59.1%)
- permanent neonatal diabetes mellitus (59.0%)